Pharma BD Deal Intelligence

Thermo Fisher Scientific Inc. / PPD Inc.

2021 · Acquisition/Merger · $17.4B · Complete

Announcement Sentiment

Strongly positive

Outcome Score

Worked — the deal delivered on its rationale.

Thermo Fisher Scientific acquired PPD, a leading clinical research organization, for $47.50 per share in cash (approximately $17.4 billion enterprise value). The acquisition expanded Thermo Fisher's clinical research services capabilities.

Key facts

Announced Apr 15, 2021
Closed Dec 08, 2021
Deal value $17.4B
Deal type Acquisition/Merger
Key assets PPD clinical trial services, PPD laboratory services

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals